ATR-107

CAT: 0804-HY-P991272-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P991272-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ATR-107 is a humanized monoclonal antibody inhibitor targeting interleukin-21 receptor (IL-21R) . ATR-107 is promising for research of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus[1].
Product Name Alternative
PF-05230900
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
98.62
Molecular Weight
(143.42 kDa)
References & Citations
[1]Hua F, et al. Anti-IL21 receptor monoclonal antibody (ATR-107) : Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol. 2014 Jan;54 (1) :14-22.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Related Products

CatalogName
HY-153462ATR-IN-24
HY-144436ATR-IN-12
HY-147565ATR-IN-13
HY-147566ATR-IN-14
HY-153393ATR-IN-21
HY-153729ATR-IN-29
HY-147568ATR-IN-16
HY-161616ATR-IN-30
HY-142671ATR-IN-5
HY-147570ATR-IN-18

Alternative Products

CatalogName
MF-0063518-01ATR-107
MBS1581682-01Research Grade Anti-Human CD360/IL21R (ATR-107)
A136441Anti-CD360/IL21R (ATR-107) Biosimilar (Monoclonal, IgG1-lambda)
552471ATR
MBS8516916-01ATR Antibody
MF-0037613-01ATR-IN-6
MF-0063522-01ATR-IN-13
MF-0063525-01ATR-IN-16
MF-0063521-01ATR-IN-12
MF-0063534-01ATR-IN-7

Popular Products